CETP-mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes

European Journal of Clinical Investigation

Volumn 42, Issue 7, 2012, Pages 709-716

  Bagdade, John D ^a,b   Knight Gibson, Carolyn ^c   Simpson, Nancy ^c   Gerkin, Richard ^d   Alaupovic, Petar ^c   Reardon, Christopher ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein; Cholesteryl ester transfer protein (CETP); Cholesteryl esters; Immunoaffinity chromatography; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TG RICH APOLIPOPROTEIN B CONTAINING LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ADULT; AGED; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHROMATOGRAPHY; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84862624435     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02636.x     Document Type: Article

References (40)

1. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. J Clin Invest 1991;21:161-7.
2. Chang CK, Tso TK, Snook JT, Huang YS, Lozano RA, Zipf WB. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose. Acta Diabetol 2001;38:37-42.
3. Colhoun HM, Scheek LM, Rubens MB, Van Gent T, Underwood SR, Fuller JH et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001;50:652-9.
4. Jiang XC, Zhou HW. Plasma lipid transfer proteins. Curr Opin Lipidol 2006;17:302-8.
5. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-66.
6. Bagdade JD, Subbaiah PV, Ritter MC. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 1991;87:1259-65.
7. Le Goff W, Guerin M, Chapman MJ. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacol Ther 2004;101:17-38.
8. Guérin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Proatherogenic role of elevated CE transfer from HDL to VLDL and dense LDL in Type 2 diabetes. Arterioscler Thromb Vasc Biol 2001;21:282-8.
9. Bagdade JD, Lane JT, Subbaiah PV, Otto MD, Ritter MR. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes. Atherosclerosis 1993;104:69-77.
10. Riemens SC, Van Tol T, Sluiter WJ, Dullaart RPF. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998;140:71-9.
11. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-61.
12. Marzetta CA, Meyers TJ, Albers JJ. Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among apoB-containing lipoprotein subpopulations. Arterioscler Thromb Vasc Biol 1993;13:834-41.
13. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families. Prog Lipid Res 1991;30:105-38.
14. Lee DM, Alaupovic P, Knight-Gibson C, Bagdade JD. Apolipoprotein-defined lipoprotein subclasses as acceptors of cholesteryl esters transferred by CETP in healthy subjects. Eur J Clin Invest 2008;38:734-42.
15. Ritter MR, Bagdade JD. Contribution of glycaemic control, endogenous lipoproteins and cholesteryl ester transfer protein to accelerate cholesteryl ester transfer in IDDM. Eur J Clin Invest 1994;24:607-14.
16. Bagdade JD, Stein E, Ritter MC. Probucol normalizes cholesteryl ester transfer in insulin-dependent diabetes mellitus. Diabetes Care 1995;18:1341-6.
17. Lee DM. A simple and sensitive method in using the ratios of cholesteryl ester molecular species as indexes of oxidative stress in plasma and lipoprotein fractions. Atherosclerosis 1999;146:221-35.
18. Alaupovic P. The concept of apolipoprotein-defined lipoprotein families and its clinical significance. Curr Atheroscler Rep 2003;5:459-67.
19. Zheng L, Khoo C, Furtado J, Sacks FM. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 2010;121:1727-34.
20. Ogawa Y, Fielding CJ. Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein. Methods Enzymol 1985;111:274-85.
21. Eisenberg S. Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters. J Lipid Res 1985;26:487-94.
22. Lagrost L. Regulation of cholesteryl ester protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994;1215:209-36.
23. Barter P, Rye K-A. Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin Exp Pharmacol Physiol 1994;21:663-72.
24. Dullaart RPF, Groener JEM, Erkelens DW. Effect of the composition of very low and low density lipoproteins on the rate of cholesteryl ester transfer from high density lipoproteins in man, studied in vitro. Eur J Clin Invest 1987;17:241-8.
25. Chapman MJ, LeGoff W, Guerin M, Kontush A. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J 2010;31:149-64.
26. Bagdade JD, Subbaiah PV. Abnormal high density lipoprotein composition in type 1 diabetic women. J Lab Clin Med 1989;113:235-40.
27. Bagdade JD, Subbaiah PV. Whole plasma and high density lipoprotein subfraction surface lipid composition in insulin-dependent diabetic males. Diabetes 1989;38:1226-30.
28. Guerci B, Igau B, Ziegler O, Crea T, Fruchart JC, Drouin P et al. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type 1 diabetic patients. Metabolism 1996;45:430-4.
29. Bagdade JD, Ritter MC, Lithell H, Rosenson R, Bassett D. Reduced cholesteryl ester in plasma of patients with lipoprotein lipase deficiency. J Lipid Res 1996;37:1696-703.
30. Nikkila EA, Huttunen JK, Enholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 1977;26:11-21.
31. Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 2009;297:E271-88.
32. Schade D, Eaton RP, Friedman NM, Spencer WJ. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diabetologia 1980;19:35-9.
33. Bagdade JD, Dunn FL, Eckel R, Ritter MC. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase in insulin-treated diabetes mellitus. Arterioscler Thromb 1994;14:1933-9.
34. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-74.
35. Morton RE. Free cholesterol is a potent regulator of lipid transfer protein function. J Biol Chem 1988;263:12235-41.
36. Lee SE, Campos M, Lemuel M, Sacks FM. LDL-containing apoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol 2003;23:853-8.
37. Koren E, Koscec M, Corder C, Knight-Gibson C, Lee DM, Alaupovic P. Differential atherogenicity of complex apoB-containing lipoprotein particles. Atherosclerosis 1994;109:217-8.
38. Lillis AP, Mikhailenko I, Strickland DK. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 2005;3:1884-93.
39. Hussain MJ, Peakman M, Gallati H, Lo SS, Hawa M, Viverti GC et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996;39:60-9.
40. Ruan XZ, Moorhead JF, Tao JL, Ma JL, Wheeler DC, Powis SH et al. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 2006;26:1150-5.